Bioceros provides services related to the preclinical development of monoclonal antibodies and generation protein-producing cell lines.
Business Model: Consulting
Revenue: $0
Employees: 11-50
Bioceros was acquired by
Epirus Biopharmaceuticals.
The acquisition happend on 2015-09-09.
Details of the transaction were not public
Address:
City: Utrecht
State: Utrecht
Zip:
Country: The Netherlands
Bioceros B.V. operates as a biopharmaceutical research and development contract organization. The company focuses on providing a range of technical and scientific expertise ranging from discovery research to pre-clinical development. Its services include assay development and quantification, pre-clinical development, molecular biology, cell biology and immunology, protein expression in various systems, upscaling/fermentation, protein purification, and consulting services. The company offers its services to other biotech companies, academic institutions, and pharmaceutical companies. Bioceros B.V. was founded in 2003 and is based in Utrecht, the Netherlands.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2011 | Grant | $2.3M | 1/2008 | Venture Round | 1 | - |
Thuja Capital Thuja Capital |
9/2005 | Private Equity Round | 1 | - |
Forbion Capital Partners Forbion Capital Partners |
1/2008 | Venture Round | 1 | - |
Thuja Capital Thuja Capital |
9/2005 | Private Equity Round | 1 | - |
Forbion Capital Partners Forbion Capital Partners |
---|
Announced Date | Name | Price |
---|---|---|
9/2005 | Cilian AG |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|